(8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate


Chemical Name: (8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate
CAS Number: 22235-81-0
Product Number: AG00C2WH(AGN-PC-02WIU2)
Synonyms:
MDL No:
Molecular Formula: C19H27NO3
Molecular Weight: 317.4226

Identification/Properties


Computed Properties
Molecular Weight:
317.429g/mol
XLogP3:
2.6
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
6
Exact Mass:
317.199g/mol
Monoisotopic Mass:
317.199g/mol
Topological Polar Surface Area:
49.8A^2
Heavy Atom Count:
23
Formal Charge:
0
Complexity:
391
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
3
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



N-Isopropylnoratropine, also known as ipratropium bromide, is a pharmaceutical compound commonly used in the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Its mechanism of action involves acting as a bronchodilator by blocking the action of acetylcholine at muscarinic receptors in the airways, thereby helping to relax smooth muscles and improve airflow to the lungs. In chemical synthesis, N-Isopropylnoratropine serves as a key reagent in the preparation of various pharmaceutical compounds and organic molecules. Its structural properties make it a valuable building block during the synthesis of complex organic structures, particularly those involving the modification of tropane alkaloids. Additionally, its quaternary ammonium nature and unique stereochemistry offer opportunities for selective functional group transformations and stereocontrol in multi-step synthesis pathways. Overall, N-Isopropylnoratropine plays a crucial role in the realm of chemical synthesis, enabling the creation of novel compounds with therapeutic potential and advancing the field of medicinal chemistry.